Enovis Corp
NYSE:ENOV
Market Cap (Intraday) | 3.31B |
Current PE | 12.95 |
Forward PE | 27.85 |
2yr Forward PE | 23.48 |
10-Day MA | $58.42 |
50-Day MA | $58.40 |
200-Day MA | $100.90 |
Enovis Corp Stock, NYSE:ENOV
2711 Centerville Road, Suite 400, Wilmington, Delaware 19808
United States of America
Phone: +1.302.252.9190
Number of Employees: 16200
Description
Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Medical Technology and Fabrication Technology. The Medical Technology segment develops, manufactures and distributes medical devices used for rehabilitation, pain management and physical therapy. The Fabrication Technology develops, manufactures and supplies consumable products and equipment. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.